Table 5

 Pharmacological treatment of women with atrial fibrillation, April 2001 to March 2002

Age group, n (%)
<45 years45–54 years55–64 years65–74 years75–84 years>85 years<75 years⩾75 yearsAll ages
Treatment(n = 29)(n = 34)(n = 127)(n = 368)(n = 612)(n = 284)(n = 558)(n = 896)(n = 1454)
CCB, calcium-channel blocker.
*Excluding dihydropyridines.
†Includes quinidine, disopyramide, propafenone and flecainide.
‡Warfarin or aspirin or clopidogrel.
§β-Blocker or rate-limiting CCB or digoxin.
¶Class 1 antiarrhythmic or amiodarone or sotalol.
β-Blocker1 (3.4)6 (17.6)43 (33.9)96 (26.1)178 (29.1)45 (15.8)146 (26.2)223 (24.9)369 (25.4)
CCB*5 (17.2)11 (32.4)73 (57.5)165 (44.8)267 (43.6)71 (25.0)254 (45.5)338 (37.7)592 (40.7)
Digoxin2 (6.9)11 (32.4)43 (33.9)159 (43.2)303 (49.5)177 (62.3)215 (38.5)480 (53.6)695 (47.8)
Class I antiarrhythmics†3 (10.3)4 (11.8)8 (6.3)13 (3.5)8 (1.3)1 (0.4)28 (5.0)9 (1.0)37 (2.5)
Amiodarone2 (6.9)6 (17.6)13 (10.2)47 (12.8)73 (11.9)12 (4.2)68 (12.2)85 (9.5)153 (10.5)
Sotalol2 (6.9)2 (5.9)12 (9.4)26 (7.1)29 (4.7)7 (2.5)42 (7.5)36 (4.0)78 (5.4)
Warfarin5 (17.2)14 (41.2)62 (48.8)176 (47.8)246 (40.2)60 (21.1)257 (46.1)306 (34.2)563 (38.7)
Aspirin2 (6.9)4 (11.8)48 (37.8)151 (41.0)290 (47.4)159 (56.0)205 (36.7)449 (50.1)654 (45.0)
Clopidogrel0 (0.0)0 (0.0)4 (3.1)13 (3.5)19 (3.1)8 (2.8)17 (3.0)27 (3.0)44 (3.0)
Any antithrombotic‡7 (24.1)16 (47.1)96 (75.6)308 (83.7)495 (80.9)209 (73.6)427 (76.5)704 (78.6)1131 (77.8)
Negative chronotropes§7 (24.1)16 (47.1)91 (71.1)279 (75.8)466 (76.1)216 (76.1)393 (70.4)682 (76.1)1075 (73.9)
Any antiarrhythmic¶7 (24.1)11 (32.4)32 (25.2)81 (22.0)108 (17.6)20 (7.0)131 (23.5)128 (14.3)259 (17.8)